Abstract
Objective: In order to overcome the insolution and low bioavailability of the vitexin in vivo, β-cyclodextrin-vitexin (β-CD-vitexin) microspheres were prepared, and their effects on the proliferation of SW480 cells were observed.
Methods: Scanning electron microscopy, ultraviolet spectrum, Fourier transform infrared spectroscopy, and release rate analysis identified the formation of β-CD-vitexin microspheres. MTT assay detected the effect of β-CD-vitexin microspheres on tumor cell proliferation at 6, 12, 24, and 48 h. Fluorescence microscopy and flow cytometry were used to observe the effect of β-CD-vitexin microspheres on the apoptosis of SW480 cells. The mRNA expression of the p53 gene was measured by qPCR.
Results: β-CD-vitexin microspheres were successfully prepared. SW480 cell proliferation was inhibited by 0.1, 0.2, and 0.4 mg/mL of β-CD-vitexin microspheres in a dose- and time-dependent manner, and the mechanism of proliferation inhibition was related to cell apoptosis caused by the upregulated expression of p53 gene.
Conclusion: The preparation of β-CD-vitexin sustained release microspheres is feasible, and β-CDvitexin microspheres have potential anti-colorectal cancer value.
Keywords: β-CD-vitexin microspheres, Preparation, Identification, SW480 cell proliferations, microspheres.
Graphical Abstract
[http://dx.doi.org/10.1016/j.phymed.2015.11.003] [PMID: 26902402]
[http://dx.doi.org/10.1016/j.jchromb.2010.05.023] [PMID: 20570577]
[http://dx.doi.org/10.1016/j.fitote.2016.09.011] [PMID: 27693342]
[http://dx.doi.org/10.1186/s40659-019-0214-y] [PMID: 30797236]
[http://dx.doi.org/10.3892/mmr.2018.8394] [PMID: 29328424]
[http://dx.doi.org/10.2174/156720112800389070] [PMID: 22283645]
[http://dx.doi.org/10.1007/BF03189986] [PMID: 1499596]
[http://dx.doi.org/10.3390/molecules22101668] [PMID: 28991152]
[http://dx.doi.org/10.2174/1567201817666200708114738] [PMID: 32640958]
[http://dx.doi.org/10.3390/molecules22091513] [PMID: 28891961]
[http://dx.doi.org/10.1016/j.lwt.2012.11.011]
[http://dx.doi.org/10.1016/j.carbpol.2015.06.014] [PMID: 26256184]
[http://dx.doi.org/10.3390/molecules22122175] [PMID: 29292740]
[http://dx.doi.org/10.3390/bioengineering4030074] [PMID: 28952553]
[http://dx.doi.org/10.25258/ijcprr.v8i03.9206]
[http://dx.doi.org/10.22159/ajpcr.2020.v13i5.37229]
[http://dx.doi.org/10.1097/MD.0000000000028228] [PMID: 34918685]
[http://dx.doi.org/10.1186/s12906-017-1956-0] [PMID: 28978315]
[PMID: 28979325]
[http://dx.doi.org/10.1016/j.matlet.2019.127114]
[http://dx.doi.org/10.1007/s13204-018-0798-5]
[http://dx.doi.org/10.1002/ptr.4841] [PMID: 22976055]
[http://dx.doi.org/10.13286/j.cnki.Chinhosppharmacyj.2016.05.08]
[http://dx.doi.org/10.1002/ptr.3186] [PMID: 20878708]